imiquimod topical

Adult Dosing .

Dosage forms:  CRM: 3.75%, 5%

condyloma acuminata, external

[3.75% crm]

Dose: apply qhs; Max: 8wk; Info: apply until total clearance or max duration; leave on x8h; 1st-line agent

[5% crm]

Dose: apply 3x/wk at bedtime; Max: x16wk; Info: apply until total clearance or max duration; leave on x6-10h; 1st-line agent

actinic keratosis

[3.75% crm]

Dose: apply qhs x2wk, off x2wk; Max: 2 actuations/application; Info: for immunocompetent pts; repeat course x1

[5% crm]

Dose: apply 2x/wk at bedtime x16wk; Max: 1 pkt/application; Info: for immunocompetent pts; limit tx area to 25 cm^2 on face or scalp

basal cell CA, superficial

[apply 5% 5x/wk at bedtime x6wk]

Info: for immunocompetent pts; limit tumor area to 2 cm diameter; not for use on face, hands, feet

genital HSV, antiviral-resistant (off-label)

[apply 5% 3x/wk at bedtime]

Info: for immunocompromised pts; leave on x8h

Peds Dosing .

Dosage forms:  CRM: 3.75%, 5%

condyloma acuminata, external

[3.75% crm, <12 yo (off-label)]

Dose: apply qhs; Max: 8wk; Info: apply until total clearance or max duration; leave on x8h; 1st-line agent

[5% crm, <12 yo (off-label)]

Dose: apply 3x/wk at bedtime; Max: x16wk; Info: apply until total clearance or max duration; leave on x6-10h; 1st-line agent

[3.75% crm, 12 yo and older]

Dose: apply qhs; Max: 8wk; Info: apply until total clearance or max duration; leave on x8h; 1st-line agent

[5% crm, 12 yo and older]

Dose: apply 3x/wk at bedtime; Max: x16wk; Info: apply until total clearance or max duration; leave on x6-10h; 1st-line agent

genital HSV, antiviral-resistant (off-label)

[12 yo and older]

Dose: apply 5% 3x/wk at bedtime; Info: for immunocompromised pts; leave on x8h